SOURCES SOUGHT
65 -- The Pacific Region Tri-Service Regional Business Office (TRBO) Region 12 announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Basic Urologicals Urinary Catheters.
- Notice Date
- 11/23/2009
- Notice Type
- Sources Sought
- NAICS
- 423450
— Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- Contracting Office
- Pacific Regional Contr Ofc TAMC, ATTN: MCAA PC BLDG 160, 160 Krukowski Road, Honolulu, HI 96859-5000
- ZIP Code
- 96859-5000
- Solicitation Number
- W81K02-10-T-3103
- Response Due
- 12/15/2009
- Archive Date
- 2/13/2010
- Point of Contact
- Mary L. Summers, 8084333686
- E-Mail Address
-
Pacific Regional Contr Ofc TAMC
(mary.summers1@us.army.mil)
- Small Business Set-Aside
- N/A
- Description
- The primary objective of this program is to standardize the quality of care across the regions based on the critical balance of clinical efficacy and value determination that represents the clinically preferred product or source(s) at the best possible price. It is also intended that standardized products be obtained through the Department of Defense Prime Vendor Program. As a clinically driven program, products will be selected based on their ability to meet the clinical evaluation expectations as a primary consideration. Price is the second factor in the decision and should demonstrate cost containment, cost avoidance and/or cost savings. The major Medical Treatment Facilities (MTFs) in the Pacific Region, TRBO Region 12 area include but are not limited to Tripler Army Medical Center, U.S. Naval Hospital Okinawa, U.S. Naval Hospital Guam, U.S. Naval Hospital Yokosuka, MEDDAC-K Seoul, 374th Medical Group Yokota Air Base, 18th Medical Group Kadena Air Base. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia (DSCP), Directorate of Medical Materiel. In order to participate, your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendors for the program. This is pursuant to the DAPA clause by which DAPA holders agree to the standardization process and to allow Prime Vendors to distribute their products. This RFRIAQ is a supplement to the Prime Vendor Program and is not a contract. For additional information regarding DSCPs Prime vendor program please access their web site at https://dmmonline.dscp.dla.mil The resulting Regional Incentive Agreement (RIA) will be for a base period of two years (24 months) from date of selection with three 12-month option periods. Anticipated selection date is January 2010. The evaluation will be based on technical, clinical, and pricing factors. The Technical/Company and Clinical/Performance evaluation factors, when combined, are considered significantly more important than cost or price. As the technical and clinical evaluation results become more equal, price will become more important. The selection will be determined utilizing best value/ trade-off criteria. The selection of a single vendor is anticipated. However, if no single vendor can meet the total requirement of the Region, the Government reserves the right to make two or more selections for RIAs. In this event, selection would be based on a combination of MTF preference and product availability. Point of Contact: Mary Summers, TRBO Team Leader 808-433-3686, mary.summers1@us.army.mil Cheryl Janus, RN, TRBO Clinical Analyst 808-433-7985, cheryl.janus@amedd.army.mil B. Products & Performance Required. The Pacific Region is seeking product line items in the category of Basic Urologicals Urinary Catheters, which at a minimum includes the high volume lines below. Within this region, this product line has an estimated annual dollar requirement of $204,528.34 This forecast is based on historical prime vendor sales during a recent 12-month period. The top high volume usage lines for this project include: Part NumberItem DescriptionAnnual Cost (PV) 300016ACATHETER FOLEY TRAY COMPLETE CARE 16FR$122,868 303016ACATHETER FOLEY 16FR BARDEX IC PLUS$35,216 300018ACATHETER FOLEY TRAY 18FR$11,125 301216ACATHETER FOLEY 16FR CRITICORE TRAY$6,789 897216CATHETER FOLEY 16FR BARDEX SILICONE$6,165 895916TRAY FOLEY WITH SILICONE COATED$4,126 0166SI22CATHETER FOLEY 22FR 30CC LATEX IC$3,290 772415TRAY CATHETER URETHRAL 15FR$2,462 0102SI18CATHETER FOLEY 18FR 5CC 2WAY RED LATEX$1,248 318116FOLEY CATH, COATED LATEX, 2-WAY$983 C. Instructions to Vendors DAPA holders interested in participating in this standardization initiative should email their (1) Company name and address, (2) Point of Contact (POC) (Name and Phone Number, Fax Number, and E-mail address) to mary.summers1@us.army.mil AND cheryl.janus@amedd.army.mil. Submissions must be received by 5:00 post meridiem (p.m.) Hawaii Standard Time (HST) on the specified closing date/time of this solicitation. Vendors that fail to meet this submittal deadline will be disqualified from participating. All e-mail communications between vendors and the region must be digitally signed. This process will include vendor requirements to provide electronic responses to technical criteria, no charge product samples and literature for clinical evaluation, and submission of electronic best price quotes. Due to the potential for email to be lost in transmission, vendors are strongly encouraged to confirm with the Regional POC stated above that their initial submission, quotes, and literature or other requested information has actually arrived at the Regional TRBO. Receipt should be confirmed early enough to allow adequate time for resubmission before the due date/time, should a problem occur with the first submission. The region reserves the right to cancel, repost, or reissue the FBO if industry response is low. D. Source Selection Procedures The Tri-Service Product Review Boards (TPRBs) are the governing body of the standardization process and program. These boards include clinicians and logisticians from the MTFs within the Pacific Region. The board is chaired by the Designated Senior Logistician (DSL). The DSL is the deciding official for this initiative. The Pacific Region TPRB is Co-Chaired by a physician from Naval Hospital Yokosuka and an Air Force Nurse Corps officer assigned to the Hawaii Multi Service Marketing Management Office (MSMMO). The Region intends to evaluate quotes and select a vendor or vendor(s), without discussion. Vendor quotes should contain the vendor's best product matches for the products or product lines requested in this announcement. Vendor quotes should contain the vendor's best responses to all technical and/or company questions listed in this announcement. Vendor quotes should contain the vendor's best tiered-pricing discounts off of the vendor's DAPA pricing (based on committed volume of 80% of the total requirements of the MTFs in the Pacific Region). Additionally, the Region reserves the right to conduct discussions and request revised quotes, if it is determined to be necessary. Interested vendors are to respond to this Federal Business Opportunity (FBO) announcement by emailing their intent to participate to the above POC by the required response date. This source selection procedure is a one-step process. The TRBO will request responses to the technical/company criteria, the no charge literature and no charge sample sets, and best value pricing from the vendor in a one-step source selection process. Vendors will have 30 calendar days to respond to the TRBO with their technical/company criteria, delivery of the no charge literature and no charge sample set to the participating MTFs, and submission of best value price quotes. Vendors technical criteria response will be in a prescribed electronic spreadsheet format. Best value pricing will be in a prescribed electronic spreadsheet format, based upon the total requirements of the Pacific Region. Vendors that fail to respond to the technical/company criteria or fail to send the no charge literature, and/or the no charge sample set, or fail to provide a best value price quote will be disqualified from further consideration in the standardization initiative. No charge literature and no charge samples must be received by the participating MTFs by close of business (COB) 5:00 PM HST, 30 days after the date of request to supply samples. All vendors must send the TRBO verification regarding the date of shipment. All communications of significant acquisition milestones (such as invitations to participate, or notices of disqualification) must be digitally signed. Vendors that have been disqualified will be notified in writing by e-mail at the conclusion of the process. Acceptability for purposes of evaluation of technical/company criteria is defined as follows: 1) based on the vendors responses, the evaluators have reasonable confidence the line of products and/or services submitted meet the medical standards of care of the community, applicable to such products or services, 2) the vendors information provided is factually correct. Any misrepresentation of information will disqualify the vendor from further consideration. The specific standard for technical acceptability will be set forth with the individual statement of each criterion, as required. The no charge samples to be provided are as follows: Basic Urologicals Urinary Catheters a) Pediatric antimicrobial Foley Catheter 6 Fr W/1.5 cc balloon - One Each 8 FrW/3 cc balloon One Each 10 Fr W/3 cc balloon One Each b) Antimicrobial Foley Catheter 12 Fr W/5 cc balloon One Each 16 Fr W/5 cc balloon One Each 18 Fr W/5 cc balloon One Each c) Antimicrobial Foley Catheter 16 Fr W/30 cc balloon One Each 20 Fr W/30 cc balloon One Each Vendors that do not meet the deadline to deliver the literature and samples by the deadline or fail to send literature and samples to the MTFs will be disqualified from further consideration in this standardization initiative. The designated MTFs that will be participating in the clinical evaluation are: Tripler Army Medical Center, U.S. Naval Hospital Guam, US Naval Hospital Yokosuka Japan, US Naval Hospital Okinawa Japan, 35th MDG Misawa AB, Japan and the 36th MDG Andersen AB, Guam. The no charge literature and no charge sample sets are required to be shipped to the following MTFs: Vendors that do not ship both literature and sample sets via UPS/DHL/FEDEX to the following six addresses will be disqualified from the standardization process. Tripler Army Medical Center ATTN: Cheryl Janus & George Fitzgerald, TPRB Standardization Committee TPRB Standardization Samples Logistics Division, Materiel Branch Bldg 161 Krukowski Road Honolulu, Hawaii 96859-5000 (808) 433-1711/ 1737 US Naval Hospital Guam ATTN: LCDR John Hicks, NC, USN & Mr. Johnny Duenas TPRB Standardization Samples Farenholt Road Bldg 1, Room L103 Agana Heights, Guam 96910 671-344-9671 US Naval Hospital Okinawa Japan ATTN: HMC A. Alonzo, USN & LT D. Salinas, NC, USN TPRB Evaluation Samples Bldg 6000, Camp Lester Chatan-Cho, Nakagami-Gun, Okinawa, Japan 904-0103 011-81-611-743-7815 US Naval Hospital Yokosuka ATTN: Mr. Rockie Ramirez & CDR A. Acevedo, NC.USN TPRB Standardization Samples 1-Chome, Honcho, Yokosuka, Kanagawa 238-0041 Aomori-Ken, Japan 033-0012 011-81-311-766-6008 35th Medical Group, Misawa, Japan ATTN: Capt J. Franks, NC, USAF & Capt J. Ulrich, USAF TPRB Standardization Samples SGSL Bldg 99 FM 5205 Misawa AB, Japan 1-Chome, Hirahata, Misawa-Shi Aomori-Ken, Japan 033-0012 011-81-311-766-6008 36th MDG Andersen AB, Guam ATTN: Capt Felicia Sherlin & MSgt Terry Mosely TPRB Clinical Evaluation Samples Unit 14010, Bldg 26001, Carolines Avenue Andersen AB Yigo, Guam 96929 671-366-6634 Specific Clinical Product Teams (CPTs), at the designated MTFs, will evaluate the clinical/performance criteria using a likert type scale, with a one to five rating. One (1) = Strongly Disagree; Two (2) = Disagree; Three (3) = Neutral; Four (4) = Agree; Five (5) = Strongly Agree. The evaluating CPTs, which consist of physicians, nurses, allied health professionals, and technicians from the participating MTFs will evaluate the products based on the evaluation criteria below. The TPRB CPT intends that clinical evaluations be conducted in a non-clinical (non-patient) setting. The Region intends to evaluate quotes and select a vendor or vendor(s), on initial submission/quotes. The region intends to evaluate quotes and select a vendor or vendors, on initial submission/quote, without discussion. However, the Region reserves the right to conduct discussions and request revised quotes, if it is determined to be necessary. The Region reserves the right to reject all quotes and cancel the RFQRIA if it is determined to be in the governments best interest. Price will be analyzed based on the vendors anticipated Post Standardization Costs. Post standardization costs will be calculated for each vendor by applying the vendors offered prices to the anticipated annual usage of the region. Unmatched items will be represented in the Post Standardization Cost at the current suppliers non-discounted price. Among the products and sources that are determined to be clinically preferred, the best price (Post Standardization Cost) will be the deciding factor. Source Selection Procedures The Tri-Service Product Review Board (TPRB) for the Pacific Region is the governing bodies of the standardization process and program. This board includes clinicians and logisticians from the MTFs within the Pacific Region. The board is chaired by the Designated Senior Logistician (DSL). They are the deciding officials for this initiative. The Pacific Region TPRB is Co-Chaired by a physician from Naval Hospital Yokosuka and an Air Force Nurse Corps officer assigned to the Hawaii Multi-Service Marketing Management Office (MSMMO). The Region intends to evaluate quotes and select a vendor or vendor(s), without discussion. Technical/Company Criteria: During the pre-source selection procedures, the CPT validated/approved the equally weighted technical/company criteria outline below: 1.Vendors must manufacture and/or distribute a complete product line of Basic Urologicals - Urinary Catheters. A complete line of product is defined as the Medical Treatment Facilities (MTFs) requirements for usage items in the product line. Usage items are defined in the Medical Surgical Prime Vendor contract statement of work as DAPA items ordered at least once per month, and at least one unit per order. At a minimum, a complete product line includes the following products in the following sizes: 1) Pediatric antimicrobial Foley Catheter in sizes: 6Fr (Balloon size 1.5cc), 8Fr (Balloon size 3cc) and 10Fr (Balloon size 3cc); 2) Catheters 12 Fr to 24 Fr (Balloon size 5cc); Catheters 16 Fr to 24 Fr (Balloon size 30cc). 2. Vendors must have a DAPA or be in the process of applying for a DAPA number for Basic Urological - Urinary Catheters. Provide the DAPA number or proof of the application process with the initial submittal. Vendors that fail to have a DAPA or show a lack of progress in obtaining a DAPA will be disqualified. 3. Vendors must have a separate agreement with the prime vendor Cardinal Health for distribution in this Region and provide certification of this with the initial submittal. Vendors whose products are not available through the regional PV will be disqualified. 4.Vendors must provide discounts off DAPA for all products included in this standardization initiative. Where lower FSS prices are available, DAPA holders are required by previous agreement to provide the FSS price as their DAPA price. Therefore, FSS prices do not represent a discount off DAPA. 5.Vendors must provide latex free Basic Urologicals Urinary Catheters. 6.Vendors must provide Foley catheters which have an antimicrobial property. 7.Vendor must provide a full description of the nature/components of their respective antimicrobial properties for the Foley catheters. 8. Vendor must provide a sterile packaging which clearly shows the expiration date of the catheter. 9. Vendor must provide the information on the location of the Latex Free disclosure, whether it is on the individual packaging or on the shipping/storage box. 10. Vendor must provide package labeling which clearly shows the size (French), length and balloon size of the contents. 11. Vendor must provide individually packaged sterile Foley catheters. 12. Vendor must provide individually packaged sterile straight urinary catheters. Clinical/Performance Criteria: 1. Packaging opens easily, without tearing of any edges and allows for presentation on to a sterile field. (Packaging which tears or heat-sealed edges separate unevenly will contaminate both the catheter and the sterile field.) Addresses patient safety infection control and cost. a. The tabs for opening the package separate easily and provide an even separation of the heat sealed edges. b. This criterion will be evaluated by the clinician performing the actual opening of the package and the placement of the catheter. c. The evaluators will carefully open the packaging, using the tabs at the end and separate the package. The expectation is that the package heat sealed edges will separate evenly and the catheter can be placed without contamination of the catheter or the sterile field. 2. The surfaces of the catheter are smooth, without areas of uneven distribution of the catheter material.(Uneven distribution of the catheter material will be abrasive to the sensitive skin of the urethra and cause pain and potential for bleeding) Addresses patient safety and comfort. a. The catheter will be smooth. b. This criterion will be evaluated by each clinician carefully examining, both visually and with tactile inspection, for overall smoothness and the lack of poor distribution of the material. c. The expectation is that the catheter will be smooth. 3. The inflatable balloon ring segment is attached securely and is embedded in the catheter, avoiding a large bump. (A raised area, caused by the inflatable balloon ring segment can be abrasive to the urethral mucous membrane and cause bleeding and pain) Addresses patient safety and comfort. a. The inflatable ring segment is embedded in the catheter without causing a bump. b. This criterion will be evaluated by each clinician carefully examining, both visually and with tactile inspection, the inflatable balloon ring segment for any raised bumpy areas. c. The expectation is that the inflatable balloon ring segment is embedded in the catheter to avoid a potential traumatic raised bumpy area. 4. The inflatable balloon inflates evenly and remains inflated after removing the balloon inflating syringe. (Cuff must inflate evenly to provide complete sealing of the opening from the bladder to the urethra otherwise urine will leak around the catheter) Addresses patient comfort, patient safety and infection control. a. Cuff will clearly inflate in an even circumferential fashion and will remain inflated after inflation syringe is removed. b. This criterion will be evaluated by each clinician using the inflating syringe, inflating the balloon and removing the syringe. The balloon will be visually and tactile inspected for even inflation and for remaining inflated. c. The expectation is that the cuff will evenly, and in a circumferential manner, inflate and remain inflated after removing syringe 5. The inflatable balloon deflates completely and evenly when the solution is extracted using the syringe via the balloon inflation tail of the catheter. (A balloon cuff is required to deflate evenly to avoid the bunching of material which could abrade the mucous membrane when withdrawing the catheter) Addresses patient safety and comfort. a. Cuff will deflate completely and evenly. b. This criterion will be evaluated by each clinician using the syringe into the balloon activation tail of the catheter, withdrawing the solution and observing, both visually and with tactile inspection, the deflated balloon. c. The expectation is that the cuff will evenly and completely deflate around the
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/MEDCOM/DADA16/W81K02-10-T-3103/listing.html)
- Place of Performance
- Address: Pacific Regional Contr Ofc TAMC ATTN: MCAA PC BLDG 160, 160 Krukowski Road Honolulu HI
- Zip Code: 96859-5000
- Zip Code: 96859-5000
- Record
- SN02009116-W 20091125/091123234826-cb9ef3992b2081f9b5b3e8d05c2b7eb3 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |